About Neuronetics (STIM)
Neuronetics, Inc. provides healthcare services. The Company develops therapies for chronic neuro health disorders. Neuronetics serves patients in the United States.
- USD1.37
- USD1.41
- USD1.33
- USD5.92
- -55.40%
- 130M
- 100.00
- 2.00M
- 90M
- 0.96
- 45.70%
Stock News
3 hours ago
CME halts futures trading on stocks, currencies and other markets, citing data center cooling issue
MarketWatch
7 hours ago
Newegg Commerce: Fundamentals Do Not Justify The Valuation, Sell
SeekingAlpha
8 hours ago
FS Specialty Lending Fund: Massive Price To NAV Discount Likely To Close Soon
SeekingAlpha
8 hours ago
Voya Global Perspectives Market Models - ETF Series Q3 2025 Commentary
SeekingAlpha